Nippon Life Global Investors Americas’s Inspire Medical Systems INSP Stock Holding History

Nippon Life Global Investors Americas’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23,380	Closed	-$3.72M	–	116
2025 Q1	$3.72M	Hold	23,380	–	–	0.18%	70
2024 Q4	$4.33M	Sell	23,380 -5,210	-18%	-$1.01M	0.2%	72
2024 Q3	$6.03M	Hold	28,590	–	–	0.26%	69
2024 Q2	$3.83M	Hold	28,590	–	–	0.17%	70
2024 Q1	$6.14M	Buy	28,590 +13,990	+96%	+$2.74M	0.29%	62
2023 Q4	$2.97M	Hold	14,600	–	–	0.17%	78
2023 Q3	$2.9M	Buy	14,600 +13,650	+1,437%	+$3.44M	0.18%	77
2023 Q2	$308K	Buy	+950	New	+$271K	0.02%	132

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nippon Life Global Investors Americas's INSP Position: Q2 2025 in Review

Nippon Life Global Investors Americas sold out of Inspire Medical Systems (INSP) in Q2 2025, closing a stake of 23,380 shares — an estimated $3.72M sold.

Nippon Life Global Investors Americas first reported a position in INSP in Q2 2023 and held it in 8 quarters. The position peaked at $6.14M in Q1 2024. 356 funds tracked by Wall St. Rank hold INSP as of Q2 2025.

Nippon Life Global Investors Americas reported no remaining Inspire Medical Systems position as of Q2 2025 after selling out during the quarter.
Nippon Life Global Investors Americas sold 23,380 Inspire Medical Systems shares in Q2 2025, an estimated $3.72M.
Nippon Life Global Investors Americas first reported a position in Inspire Medical Systems in Q2 2023 and held it in 8 quarters.
Nippon Life Global Investors Americas's Inspire Medical Systems position peaked at $6.14M in Q1 2024.
356 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2025.

Based on Nippon Life Global Investors Americas's 13F filing for Q2 2025, filed 14 Aug 2025.